BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23997935)

  • 1. Insulin and GLP-1 infusions demonstrate the onset of adipose-specific insulin resistance in a large fasting mammal: potential glucogenic role for GLP-1.
    Viscarra JA; Rodriguez R; Vazquez-Medina JP; Lee A; Tift MS; Tavoni SK; Crocker DE; Ortiz RM
    Physiol Rep; 2013 Aug; 1(2):e00023. PubMed ID: 23997935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous GLP-1 stimulates TCA cycle and suppresses gluconeogenesis and ketogenesis in late-fasted northern elephant seals pups.
    Dhillon J; Viscarra JA; Newman JW; Fiehn O; Crocker DE; Ortiz RM
    Am J Physiol Regul Integr Comp Physiol; 2021 Apr; 320(4):R393-R403. PubMed ID: 33407018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5'AMP-activated protein kinase activity is increased in adipose tissue of northern elephant seal pups during prolonged fasting-induced insulin resistance.
    Viscarra JA; Champagne CD; Crocker DE; Ortiz RM
    J Endocrinol; 2011 Jun; 209(3):317-25. PubMed ID: 21429964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose delays the insulin-induced increase in thyroid hormone-mediated signaling in adipose of prolong-fasted elephant seal pups.
    Martinez B; Soñanez-Organis JG; Viscarra JA; Jaques JT; MacKenzie DS; Crocker DE; Ortiz RM
    Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(6):R502-12. PubMed ID: 26739649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of adipose CD36 and FATP1 are associated with increased plasma non-esterified fatty acids during prolonged fasting in northern elephant seal pups (Mirounga angustirostris).
    Viscarra JA; Vázquez-Medina JP; Rodriguez R; Champagne CD; Adams SH; Crocker DE; Ortiz RM
    J Exp Biol; 2012 Jul; 215(Pt 14):2455-64. PubMed ID: 22723485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glut4 is upregulated despite decreased insulin signaling during prolonged fasting in northern elephant seal pups.
    Viscarra JA; Vázquez-Medina JP; Crocker DE; Ortiz RM
    Am J Physiol Regul Integr Comp Physiol; 2011 Jan; 300(1):R150-4. PubMed ID: 20980624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma FGF21 concentrations, adipose fibroblast growth factor receptor-1 and β-klotho expression decrease with fasting in northern elephant seals.
    Suzuki M; Lee AY; Vázquez-Medina JP; Viscarra JA; Crocker DE; Ortiz RM
    Gen Comp Endocrinol; 2015 May; 216():86-9. PubMed ID: 25857751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GH and ghrelin increase with fasting in a naturally adapted species, the northern elephant seal (Mirounga angustirostris).
    Ortiz RM; Noren DP; Ortiz CL; Talamantes F
    J Endocrinol; 2003 Sep; 178(3):533-9. PubMed ID: 12967344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of systemic, but not local, renin-angiotensin system is associated with upregulation of TNF-α during prolonged fasting in northern elephant seal pups.
    Suzuki M; Vázquez-Medina JP; Viscarra JA; Soñanez-Organis JG; Crocker DE; Ortiz RM
    J Exp Biol; 2013 Sep; 216(Pt 17):3215-21. PubMed ID: 23685967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged fasting does not increase oxidative damage or inflammation in postweaned northern elephant seal pups.
    Vázquez-Medina JP; Crocker DE; Forman HJ; Ortiz RM
    J Exp Biol; 2010 Jul; 213(Pt 14):2524-30. PubMed ID: 20581282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance.
    Sjøberg KA; Rattigan S; Jeppesen JF; Lundsgaard AM; Holst JJ; Kiens B
    J Physiol; 2015 May; 593(9):2185-98. PubMed ID: 25688993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin induces a shift in lipid and primary carbon metabolites in a model of fasting-induced insulin resistance.
    Olmstead KI; La Frano MR; Fahrmann J; Grapov D; Viscarra JA; Newman JW; Fiehn O; Crocker DE; Filipp FV; Ortiz RM
    Metabolomics; 2017 May; 13(5):. PubMed ID: 28757815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic response to a glucagon challenge varies with adiposity and life-history stage in fasting northern elephant seals.
    Crocker DE; Fowler MA; Champagne CD; Vanderlugt AL; Houser DS
    Gen Comp Endocrinol; 2014 Jan; 195():99-106. PubMed ID: 24239794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged fasting increases purine recycling in post-weaned northern elephant seals.
    Soñanez-Organis JG; Vázquez-Medina JP; Zenteno-Savín T; Aguilar A; Crocker DE; Ortiz RM
    J Exp Biol; 2012 May; 215(Pt 9):1448-55. PubMed ID: 22496280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice.
    Tura A; Pacini G; Yamada Y; Seino Y; Ahrén B
    Am J Physiol Regul Integr Comp Physiol; 2019 Jan; 316(1):R27-R37. PubMed ID: 30462524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome.
    Rodriguez R; Viscarra JA; Minas JN; Nakano D; Nishiyama A; Ortiz RM
    Endocrinology; 2012 Apr; 153(4):1684-95. PubMed ID: 22355070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans.
    Vahl TP; Paty BW; Fuller BD; Prigeon RL; D'Alessio DA
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1772-9. PubMed ID: 12679472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.